Jones Financial Companies Lllp Roivant Sciences Ltd. Transaction History
Jones Financial Companies Lllp
- $97.4 Billion
- Q3 2024
A detailed history of Jones Financial Companies Lllp transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 200 shares of ROIV stock, worth $2,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$2,226
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
319Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$734 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$732 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$602 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$464 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$394 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.84B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...